Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |